ProfileGDS4718 / 212730_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 79% 88% 100% 77% 85% 72% 73% 73% 86% 80% 80% 85% 47% 77% 56% 99% 82% 71% 57% 80% 81% 80% 93% 82% 84% 63% 96% 66% 73% 53% 79% 99% 79% 59% 93% 85% 57% 82% 75% 100% 80% 80% 98% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.6867279
GSM549102patient 115, normal, homogenized [OPG study]8.7948288
GSM549104patient 119, normal, homogenized [OPG study]14.1748100
GSM549108patient 138, normal, homogenized [OPG study]7.4728277
GSM549119patient 077, normal, homogenized [OPG study]8.4320485
GSM549133patient 032, cancer, homogenized [OPG study]7.1134672
GSM549139patient 042, cancer, homogenized [OPG study]7.219573
GSM549099patient 107, normal, homogenized [OPG study]7.0540573
GSM549109patient 139, normal, homogenized [OPG study]8.539586
GSM549110patient 046, normal, homogenized [OPG study]7.8107680
GSM549114patient 063, normal, homogenized [OPG study]7.8764980
GSM549122patient 082, normal, homogenized [OPG study]8.4398685
GSM549134patient 033, cancer, homogenized [OPG study]5.3066647
GSM549136patient 036, cancer, homogenized [OPG study]7.6217777
GSM549140patient 044, cancer, homogenized [OPG study]5.8526256
GSM549111patient 047, normal, homogenized [OPG study]12.034299
GSM549113patient 057, normal, homogenized [OPG study]8.2714482
GSM549132patient 031, cancer, homogenized [OPG study]6.9673671
GSM549137patient 038, cancer, homogenized [OPG study]5.9393357
GSM549142patient 047, cancer, homogenized [OPG study]7.5950780
GSM549100patient 110, normal, homogenized [OPG study]7.9276981
GSM549107patient 135, normal, homogenized [OPG study]7.9167580
GSM549115patient 068, normal, homogenized [OPG study]9.9717693
GSM549116patient 072, normal, homogenized [OPG study]8.1036982
GSM549120patient 078, normal, homogenized [OPG study]8.3832284
GSM549131patient 030, cancer, homogenized [OPG study]6.3450363
GSM549118patient 074, normal, homogenized [OPG study]10.536896
GSM549129patient 027, cancer, homogenized [OPG study]6.5987566
GSM549123patient 088, normal, homogenized [OPG study]7.1683473
GSM549124patient 006, cancer, homogenized [OPG study]5.7065753
GSM549126patient 015, cancer, homogenized [OPG study]7.7864779
GSM549128patient 025, cancer, homogenized [OPG study]12.572899
GSM549103patient 117, normal, homogenized [OPG study]7.6278679
GSM549117patient 073, normal, homogenized [OPG study]6.029959
GSM549138patient 041, cancer, homogenized [OPG study]9.7277693
GSM549141patient 045, cancer, homogenized [OPG study]8.6033785
GSM549130patient 028, cancer, homogenized [OPG study]5.9543857
GSM549101patient 111, normal, homogenized [OPG study]8.0060182
GSM549105patient 128, normal, homogenized [OPG study]7.3011675
GSM549106patient 134, normal, homogenized [OPG study]14.1967100
GSM549112patient 048, normal, homogenized [OPG study]7.8539680
GSM549125patient 011, cancer, homogenized [OPG study]7.7978980
GSM549127patient 024, cancer, homogenized [OPG study]11.44298
GSM549135patient 035, cancer, homogenized [OPG study]6.4894165